Literature DB >> 20222111

Proinflammatory cytokine expression profile in degenerated and herniated human intervertebral disc tissues.

Mohammed F Shamji1, Lori A Setton, Wingrove Jarvis, Stephen So, Jun Chen, Liufang Jing, Robert Bullock, Robert E Isaacs, Christopher Brown, William J Richardson.   

Abstract

OBJECTIVE: Prior reports document macrophage and lymphocyte infiltration with proinflammatory cytokine expression in pathologic intervertebral disc (IVD) tissues. Nevertheless, the role of the Th17 lymphocyte lineage in mediating disc disease remains uninvestigated. We undertook this study to evaluate the immunophenotype of pathologic IVD specimens, including interleukin-17 (IL-17) expression, from surgically obtained IVD tissue and from nondegenerated autopsy control tissue.
METHODS: Surgical IVD tissues were procured from patients with degenerative disc disease (n = 25) or herniated IVDs (n = 12); nondegenerated autopsy control tissue was also obtained (n = 8) from the anulus fibrosus and nucleus pulposus regions. Immunohistochemistry was performed for cell surface antigens (CD68 for macrophages, CD4 for lymphocytes) and various cytokines, with differences in cellularity and target immunoreactivity scores analyzed between surgical tissue groups and between autopsy control tissue regions.
RESULTS: Immunoreactivity for IL-4, IL-6, IL-12, and interferon-gamma (IFNgamma) was modest in surgical IVD tissue, although expression was higher in herniated IVD samples and virtually nonexistent in control samples. The Th17 lymphocyte product IL-17 was present in >70% of surgical tissue fields, and among control samples was detected rarely in anulus fibrosus regions and modestly in nucleus pulposus regions. Macrophages were prevalent in surgical tissues, particularly herniated IVD samples, and lymphocytes were expectedly scarce. Control tissue revealed lesser infiltration by macrophages and a near absence of lymphocytes.
CONCLUSION: Greater IFNgamma positivity, macrophage presence, and cellularity in herniated IVDs suggests a pattern of Th1 lymphocyte activation in this pathology. Remarkable pathologic IVD tissue expression of IL-17 is a novel finding that contrasts markedly with low levels of IL-17 in autopsy control tissue. These findings suggest involvement of Th17 lymphocytes in the pathomechanism of disc degeneration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20222111      PMCID: PMC2917579          DOI: 10.1002/art.27444

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  30 in total

1.  Immunohistologic study of the ruptured intervertebral disc of the lumbar spine.

Authors:  M Doita; T Kanatani; T Harada; K Mizuno
Journal:  Spine (Phila Pa 1976)       Date:  1996-01-15       Impact factor: 3.468

2.  Immunocytochemical localization of immunoglobulins in disc herniations.

Authors:  A Habtemariam; M Grönblad; J Virri; S Seitsalo; M Ruuskanen; E Karaharju
Journal:  Spine (Phila Pa 1976)       Date:  1996-08-15       Impact factor: 3.468

3.  Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model.

Authors:  J A DeLeo; R W Colburn; M Nichols; A Malhotra
Journal:  J Interferon Cytokine Res       Date:  1996-09       Impact factor: 2.607

4.  Toward a biochemical understanding of human intervertebral disc degeneration and herniation. Contributions of nitric oxide, interleukins, prostaglandin E2, and matrix metalloproteinases.

Authors:  J D Kang; M Stefanovic-Racic; L A McIntyre; H I Georgescu; C H Evans
Journal:  Spine (Phila Pa 1976)       Date:  1997-05-15       Impact factor: 3.468

5.  The inflammatory properties of contained and noncontained lumbar disc herniation.

Authors:  O P Nygaard; S I Mellgren; B Osterud
Journal:  Spine (Phila Pa 1976)       Date:  1997-11-01       Impact factor: 3.468

6.  Inflammatory cells in experimental intervertebral disc injury.

Authors:  A Kanerva; B Kommonen; M Grönblad; J Tolonen; A Habtemariam; J Virri; E Karaharju
Journal:  Spine (Phila Pa 1976)       Date:  1997-12-01       Impact factor: 3.468

7.  Presence and distribution of antigen-antibody complexes in the herniated nucleus pulposus.

Authors:  K Satoh; S Konno; K Nishiyama; K Olmarker; S Kikuchi
Journal:  Spine (Phila Pa 1976)       Date:  1999-10-01       Impact factor: 3.468

8.  Spinal nerve lesion-induced mechanoallodynia and adrenergic sprouting in sensory ganglia are attenuated in interleukin-6 knockout mice.

Authors:  Matt S Ramer; Patricia G Murphy; Peter M Richardson; Mark A Bisby
Journal:  Pain       Date:  1998-11       Impact factor: 6.961

9.  A comparative immunohistochemical study of inflammatory cells in acute-stage and chronic-stage disc herniations.

Authors:  A Habtemariam; M Grönblad; J Virri; S Seitsalo; E Karaharju
Journal:  Spine (Phila Pa 1976)       Date:  1998-10-15       Impact factor: 3.468

10.  Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1beta and TNFalpha expression profile.

Authors:  Christine Lyn Le Maitre; Judith Alison Hoyland; Anthony J Freemont
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more
  155 in total

1.  A cohort study comparing the serum levels of pro- or anti-inflammatory cytokines in patients with lumbar radicular pain and healthy subjects.

Authors:  Kun Wang; Jun-Ping Bao; Shu Yang; Xin Hong; Lei Liu; Xin-Hui Xie; Xiao-Tao Wu
Journal:  Eur Spine J       Date:  2015-12-18       Impact factor: 3.134

2.  Human mesenchymal stem cell co-culture modulates the immunological properties of human intervertebral disc tissue fragments in vitro.

Authors:  Alessandro Bertolo; Thomas Thiede; Niklaus Aebli; Martin Baur; Stephen J Ferguson; Jivko V Stoyanov
Journal:  Eur Spine J       Date:  2010-12-23       Impact factor: 3.134

3.  Injection of a polymerized hyaluronic acid/collagen hydrogel matrix in an in vivo porcine disc degeneration model.

Authors:  G W Omlor; A G Nerlich; H Lorenz; T Bruckner; W Richter; M Pfeiffer; T Gühring
Journal:  Eur Spine J       Date:  2012-04-25       Impact factor: 3.134

Review 4.  Role of cytokines in intervertebral disc degeneration: pain and disc content.

Authors:  Makarand V Risbud; Irving M Shapiro
Journal:  Nat Rev Rheumatol       Date:  2013-10-29       Impact factor: 20.543

5.  Plasmacytoid dendritic cells and memory T cells infiltrate true sequestrations stronger than subligamentous sequestrations: evidence from flow cytometric analysis of disc infiltrates.

Authors:  Andrea Geiss; Rolf Sobottke; Karl Stefan Delank; Peer Eysel
Journal:  Eur Spine J       Date:  2016-02-23       Impact factor: 3.134

6.  Role of interleukin-17 in chondrocytes of herniated intervertebral lumbar discs.

Authors:  Peng Tian; Zhi-Jun Li; Xin Fu; Xin-Long Ma
Journal:  Exp Ther Med       Date:  2015-04-24       Impact factor: 2.447

7.  Prolyl-4-hydroxylase domain protein 2 controls NF-κB/p65 transactivation and enhances the catabolic effects of inflammatory cytokines on cells of the nucleus pulposus.

Authors:  Jun Li; Wen Yuan; Shuai Jiang; Wei Ye; Hao Yang; Irving M Shapiro; Makarand V Risbud
Journal:  J Biol Chem       Date:  2015-01-29       Impact factor: 5.157

8.  Role of miR-589-3p in human lumbar disc degeneration and its potential mechanism.

Authors:  Aiqing Lu; Zhirong Wang; Suchun Wang
Journal:  Exp Ther Med       Date:  2017-12-05       Impact factor: 2.447

9.  Multiplex Epigenome Editing of Dorsal Root Ganglion Neuron Receptors Abolishes Redundant Interleukin 6, Tumor Necrosis Factor Alpha, and Interleukin 1β Signaling by the Degenerative Intervertebral Disc.

Authors:  Joshua D Stover; Niloofar Farhang; Brandon Lawrence; Robby D Bowles
Journal:  Hum Gene Ther       Date:  2019-06-11       Impact factor: 5.695

10.  CCN2 suppresses catabolic effects of interleukin-1β through α5β1 and αVβ3 integrins in nucleus pulposus cells: implications in intervertebral disc degeneration.

Authors:  Cassie M Tran; Zachary R Schoepflin; Dessislava Z Markova; Christopher K Kepler; D Greg Anderson; Irving M Shapiro; Makarand V Risbud
Journal:  J Biol Chem       Date:  2014-01-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.